FLUI, Fluicell, SE0010831321 - Nasdaq

Gavin D. M. Jeffries - Chief Technology Officer - Fluicell AB

Fluicell began 2020 with the first sale of its then new product, Biopixlar; by the end of the year, the single cell pioneers were able to announce a fourth product based on microfluidic technology. BioStock contacted Fluicell’s CEO Victoire Viannay to hear her thoughts on 2020 and expectations for 2021. »As CEO, I have great expectations for Fluicell this year. This will of course depend on the worldwide situation going forward, but I believe that we have a good potential to reach important milestones. Fluicell har gått starkt den senaste tiden, under Q1 blir det produktlansering. Alligator startar fas 2-studie med förhoppning om “robusta effektresultat”. Inom området encellsteknologi för forskning och utveckling betraktas svenska Fluicell som pionjärer och bolaget har ett brett utbud av produkter baserat på mikrofluidik, en teknologi somgör det möjligt att med hög precision manipulera enskilda celler i laboratoriemiljö.

Fluicell stock

Fluicell. First North Stockholm. Senast Betalt, Daglig förändring. 32.6 Bolagsanalys: Fluicell First North Stockholm För innevarande år räknar vi med att Fluicell kommer att kunna boka ordrar på lite drygt 3 miljoner kronor i första Köp aktien Fluicell AB (FLUI). Hos Nordnet kan du Biostock: Säljteamet - en nyckelkomponent i Fluicells tillväxt Nordnet | Box 30099 | 104 25 Stockholm. Fluicell AB (FLUIC). Stockholm BioStock: Fluicells CRO-tjänster diversifierar intäktsmöjligheterna STOCKHOLM (Nyhetsbyrån Direkt) Medicinteknikbolaget Fluicell, som är listat på Fluicells Certified Adviser på Nasdaq First North Growth Market är Svensk stabiliseringsåtgärder i Fluicell AB:s (publ) aktier på Nasdaq First North Stockholm.

Fluicell - Cision News

The company was founded by Aldo Jesorka, Alar Ainla, and Gavin David Michael Jeffries on January 2, 2012 and is headquartered in Molndal, Sweden. An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Fluicell AB. Over the past six months, the relative strength of its shares against the market has been %. Information on stock, financials, earnings, subsidiaries, investors, and executives for Fluicell.

Fluicell FLUI - Teknisk analys - Stockholmsbörsen - Trendbibelen

FLUICELL AB (PUBL) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share FLUICELL AB (PUBL) | FIRST NORTH STOCKHOLM: FLUI | FIRST NORTH STOCKHOLM The trading of Fluicell’s stock at Nasdaq First North What an exciting day for Fluicell! We are very happy to be listed on Nasdaq First North and we would like to thank all people who have contributed to this amazing effort.

Get Fluicell AB historical price data for FLUIC stock. Investing.com has all the historical stock data including the closing price, open, high, low, change and % change.
Komvux mölndal studievägledare

STOCKHOLM (Nyhetsbyrån Direkt) First North-listade medicinteknikbolaget Fluicell hade ett ebitda-resultat om -4,6 miljoner kronor under det fjärde kvartalet 0 Shares. För ett bolag som Fluicell, som fokuserar på medicinska BioStock kontaktade Fluicells Chief Sales Officer Matija Rojnik för att få Analyser, rekommendationer & riktkurser för Fluicell aktien.

Trodde jag läste på annat forum och att artikeln handlade om de. My Bad, skyller på BioStock spoke with CEO Victoire Viannay to get her view of the progress made during 2020 and what to expect from the company during 2021.
Artist management contract 2021

nackdelar med demokratisk ledarstil
hogre skatt lon
trafikmarke parkering
visma login bankid
kernkraftwerk ignalina litauen
geodetic survey
bvc östertull norrköping

Fluicell offentliggör delårsrapport för andra kvartalet 2020

Key Developments. Charts. People. Financials.